+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiac POC Testing Devices Market by Product Type, End User, Technology, Sample Type, Application - Global Forecast to 2030- Product Image
Cardiac POC Testing Devices Market by Product Type, End User, Technology, Sample Type, Application - Global Forecast to 2030- Product Image
Sale

Cardiac POC Testing Devices Market by Product Type, End User, Technology, Sample Type, Application - Global Forecast to 2030

  • PDF Icon

    Report

  • 189 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666012
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cardiac POC Testing Devices Market grew from USD 1.52 billion in 2024 to USD 1.69 billion in 2025. It is expected to continue growing at a CAGR of 12.53%, reaching USD 3.08 billion by 2030.

Setting the Scene for Cardiac Point of Care Diagnostics

The escalating incidence of cardiovascular disorders worldwide has intensified the demand for rapid, reliable diagnostics at the patient’s side. In response, point-of-care testing devices have emerged as a pivotal force in reducing time to diagnosis and improving clinical outcomes. This introduction outlines the key drivers and challenges shaping the cardiac point-of-care testing landscape, emphasizing the urgency of streamlined diagnostics in acute and chronic settings.

As healthcare systems grapple with escalating costs and mounting patient loads, decentralized testing solutions offer a compelling value proposition. By shifting critical biomarker analysis from centralized laboratories to the bedside or outpatient clinics, clinicians can access timely data to inform treatment decisions. Yet this transition is not without obstacles. Regulatory hurdles, reimbursement ambiguities, and integration with electronic health records pose significant barriers to widespread adoption.

Nevertheless, technological advancements-particularly in immunoassay sensitivity and microfluidics-are enabling smaller, more accurate, and cost-effective devices. The convergence of digital connectivity and data analytics further enhances the appeal of point-of-care platforms, paving the way for real-time monitoring and remote patient management. This report opens by establishing the foundational context for understanding how these elements converge to drive transformative change in cardiac diagnostics.

Emerging Forces Reshaping Cardiac Testing Dynamics

The cardiac testing ecosystem is undergoing a period of unprecedented transformation driven by several converging forces. First, the advent of advanced immunoassay techniques, including fluorescence-based and lateral-flow formats, has elevated analytical performance to rival traditional laboratory instruments. These breakthroughs bring laboratory-grade accuracy directly to the clinical front line, reshaping expectations for diagnostic speed and reliability.

Simultaneously, the growing emphasis on value-based care compels providers to adopt solutions that reduce hospital stays and readmissions. Point-of-care devices that deliver rapid biomarker assessment in emergency departments and cardiac care units are increasingly recognized as strategic tools for improving patient throughput and lowering overall treatment costs.

At the same time, strategic collaborations between device manufacturers, health systems, and regulatory bodies are accelerating device approvals and facilitating market entry. The integration of colorimetric and electrochemical modalities into portable platforms further diversifies the product landscape, expanding options for clinicians and patients. Together, these shifts are redefining the competitive environment and setting a new benchmark for responsiveness in cardiac diagnostics.

Evaluating the Influence of 2025 Tariffs on US Market Access

The tariff measures implemented in early 2025 introduced additional levies on imported diagnostic equipment, prompting critical adjustments across the supply chain. Device manufacturers reliant on overseas components have confronted increased production costs, compelling them to reevaluate sourcing strategies and negotiate alternative supplier agreements. Many have responded by relocating assembly lines or increasing local procurement to mitigate the tariff burden.

Clinicians and healthcare institutions faced incremental pricing pressure as distributors passed through higher costs. In response, several leading providers optimized device designs to reduce material usage and streamline manufacturing workflows. Others entered into strategic partnerships with regional suppliers to establish tariff-exempt import channels.

Despite these challenges, the tariff landscape has also catalyzed innovation. Firms have accelerated the development of modular platforms that accommodate interchangeable cartridges produced domestically, thereby circumventing import duties on finished devices. Regulatory agencies have shown flexibility in approving such modular architectures, acknowledging their potential to maintain market access and ensure continuity of patient care. Ultimately, the tariff-driven market realignment has fostered both cost-containment efforts and inventive design paradigms.

Deciphering Market Composition Through Segmentation Lenses

An in-depth examination of product categories reveals that Troponin assays command significant attention, with both Troponin I and Troponin T formats demonstrating robust adoption due to their pivotal role in acute coronary syndrome diagnosis. Concurrently, BNP tests maintain strong relevance in heart failure management, while CK-MB and Myoglobin assays find niche applications during early-phase emergency evaluation and serial monitoring protocols.

In the context of clinical settings, hospitals-particularly cardiac care units and emergency departments-constitute the primary end users of point-of-care solutions. Clinics and diagnostic laboratories complement these high-acuity environments by offering outpatient screening and follow-up services. Within hospitals, the rapid turnaround times enabled by bedside testing tools have proven instrumental in streamlining patient triage and reducing length of stay.

Technological paradigms influence device selection as well. Colorimetric and electrochemical modalities deliver cost-effective, compact solutions, whereas immunoassay platforms-spanning both fluorescence-based and lateral-flow formats-offer superior sensitivity for critical biomarkers. Sample type remains a key variable in workflow design, with plasma and serum tests favored in controlled settings and whole blood assays empowering true bedside convenience. Application segments further delineate the market, as acute coronary syndrome protocols prioritize high-sensitivity troponin testing, while chronic care pathways leverage BNP and Myoglobin assessments for ongoing heart failure management.

Unearthing Regional Nuances Across Global Markets

Regional analysis uncovers diverse growth trajectories shaped by healthcare infrastructure and regulatory frameworks. The Americas region persists as an innovation hub, with early adoption of digital connectivity features and supportive reimbursement policies driving uptake across both hospital and outpatient settings. In Europe, Middle East & Africa, centralized health systems and evolving regulatory harmonization accelerate large-scale purchases, particularly in emergency care networks seeking standardized diagnostic protocols.

Within Asia-Pacific, a combination of rising cardiovascular disease incidence and expanding primary care facilities fuels demand for portable devices. Countries with burgeoning healthcare budgets invest in decentralized testing as a cost-efficient means to broaden access, while established markets emphasize integration with telehealth initiatives to extend diagnostic reach into rural and remote areas.

Each region’s distinct combination of clinical priorities, reimbursement mechanisms, and competitive landscapes shapes procurement strategies. Manufacturers adept at navigating regional regulatory nuances and tailoring product portfolios to local needs are poised to capture significant market share. Moreover, cross-regional partnerships are emerging as a pathway to scale manufacturing efficiencies and harmonize quality standards on a global scale.

Assessing Strategic Positions of Leading Industry Players

Leading players have adopted varied strategic postures to consolidate their positions in the cardiac point-of-care segment. Established diagnostics firms leverage extensive distribution networks and deep regulatory expertise to maintain leadership in troponin and BNP testing platforms. Mid-tier innovators differentiate through nimble R&D processes and targeted device portfolios that emphasize emerging modalities such as lateral-flow immunoassays.

Several newcomers have carved out specialty niches by focusing on user-friendly interfaces and minimal sample preparation workflows, capturing attention in outpatient clinics and smaller laboratories. Partnerships between established multinationals and regional champions are accelerating localized production, expediting regulatory approvals, and strengthening customer support ecosystems.

In addition, strategic alliances with digital health companies are enhancing remote monitoring capabilities and enabling real-time data exchange with electronic health record systems. This convergence of diagnostics and digital platforms is redefining value propositions and creating new revenue streams through subscription-based analytic services.

Competitive differentiation increasingly hinges on the ability to deliver end-to-end solutions that combine reliable biomarker analysis with seamless integration into clinical workflows, underscoring the importance of service excellence alongside technological prowess.

Strategic Imperatives to Propel Competitive Advantage

Industry leaders should prioritize modular device architectures that permit rapid deployment of new assay panels without full platform redesign. Investing in interoperability standards and cloud-based analytics will ensure seamless integration with hospital information systems and telehealth frameworks. Moreover, dual focus on reducing total cost of ownership and enhancing user experience through intuitive interfaces will be critical to driving adoption in resource-constrained settings.

Diversifying supply chains to include strategically located manufacturing facilities can mitigate geopolitical risks and tariff exposures. This approach not only safeguards continuity but also enables faster turnaround times for emerging market approvals. In parallel, cultivating regulatory liaisons and participating in standards-setting initiatives will help to streamline certification pathways and preempt future compliance challenges.

Collaborative ventures with academic institutions and clinical research networks can accelerate validation studies, while real-world evidence programs strengthen market access arguments. Finally, embedding artificial intelligence capabilities to interpret complex biomarker profiles offers a promising avenue to enhance diagnostic accuracy and deliver predictive insights for patient management.

Rigorous Framework Guiding Our Analytical Approach

Our methodology integrates a rigorous blend of secondary and primary research to ensure analytical depth and validity. Secondary sources such as peer-reviewed journals, regulatory filings, and industry white papers furnish foundational data on device specifications, approvals, and historical adoption trends. Concurrently, in-depth interviews with clinicians, laboratory managers, and procurement officers supply real-world perspectives on device utilization, unmet clinical needs, and purchasing criteria.

Quantitative data undergoes triangulation against multiple independent sources, enhancing confidence in key findings. Segmentation analyses are constructed through iterative mapping of product, end-user, technology, sample type, and application categories, ensuring comprehensive coverage of market dynamics. Geographic assessments leverage regional health economic indicators and reimbursement landscapes to refine insights on growth opportunities.

Expert panels comprised of cardiologists, clinical chemists, and device engineers review draft conclusions to validate technical accuracy and practical relevance. This multi-layered approach balances breadth with depth, delivering a robust framework for understanding the evolving cardiac point-of-care testing market.

Synthesizing Insights to Illuminate the Path Forward

The escalating convergence of diagnostic sensitivity, digital integration, and decentralized care models underscores a pivotal moment in cardiac testing. As tariffs reshape supply chains and regional nuances define adoption curves, stakeholders must navigate a complex interplay of clinical, economic, and regulatory variables.

The insights presented herein highlight the critical importance of flexible platform design, strategic supply-chain diversification, and proactive regulatory engagement. Manufacturers able to harmonize technological excellence with cost-efficiency will secure leadership positions, while end users stand to benefit from faster diagnostic turnaround and enhanced patient outcomes.

Ultimately, the cardiac point-of-care testing landscape is primed for continued growth, driven by demographic shifts and the unrelenting pursuit of healthcare value. By synthesizing this report’s findings with internal strategic priorities, organizations can chart a clear path toward sustained success in this dynamic arena.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Product Type
    • BNP
    • CK-MB
    • Myoglobin
    • Troponin
      • Troponin I
      • Troponin T
  • End User
    • Clinics
    • Diagnostic Laboratories
    • Hospital
      • Cardiac Care Unit
      • Emergency Department
  • Technology
    • Colorimetric
    • Electrochemical
    • Immunoassay
      • Fluorescence
      • Lateral Flow
  • Sample Type
    • Plasma
    • Serum
    • Whole Blood
  • Application
    • Acute Coronary Syndrome
    • Heart Failure
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Becton Dickinson and Company
  • bioMérieux SA
  • Quidel Corporation
  • Nova Biomedical, Inc.
  • Trinity Biotech plc
  • Chembio Diagnostics Systems, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cardiac POC Testing Devices Market, by Product Type
8.1. Introduction
8.2. BNP
8.3. CK-MB
8.4. Myoglobin
8.5. Troponin
8.5.1. Troponin I
8.5.2. Troponin T
9. Cardiac POC Testing Devices Market, by End User
9.1. Introduction
9.2. Clinics
9.3. Diagnostic Laboratories
9.4. Hospital
9.4.1. Cardiac Care Unit
9.4.2. Emergency Department
10. Cardiac POC Testing Devices Market, by Technology
10.1. Introduction
10.2. Colorimetric
10.3. Electrochemical
10.4. Immunoassay
10.4.1. Fluorescence
10.4.2. Lateral Flow
11. Cardiac POC Testing Devices Market, by Sample Type
11.1. Introduction
11.2. Plasma
11.3. Serum
11.4. Whole Blood
12. Cardiac POC Testing Devices Market, by Application
12.1. Introduction
12.2. Acute Coronary Syndrome
12.3. Heart Failure
13. Americas Cardiac POC Testing Devices Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Cardiac POC Testing Devices Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Cardiac POC Testing Devices Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Abbott Laboratories
16.3.3. Siemens Healthineers AG
16.3.4. Danaher Corporation
16.3.5. Becton Dickinson and Company
16.3.6. bioMérieux SA
16.3.7. Quidel Corporation
16.3.8. Nova Biomedical, Inc.
16.3.9. Trinity Biotech plc
16.3.10. Chembio Diagnostics Systems, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CARDIAC POC TESTING DEVICES MARKET MULTI-CURRENCY
FIGURE 2. CARDIAC POC TESTING DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. CARDIAC POC TESTING DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CARDIAC POC TESTING DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CARDIAC POC TESTING DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CARDIAC POC TESTING DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY BNP, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CK-MB, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY MYOGLOBIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN I, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN T, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY CARDIAC CARE UNIT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY EMERGENCY DEPARTMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY COLORIMETRIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY ELECTROCHEMICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY FLUORESCENCE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY LATERAL FLOW, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY SERUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 53. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 54. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 55. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 57. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 59. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 62. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 63. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 65. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 66. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 67. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 70. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 78. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 79. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 94. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 95. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 96. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 103. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 104. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 106. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 108. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 109. GERMANY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 112. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 114. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 116. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 117. FRANCE CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 127. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 128. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 130. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 132. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 133. ITALY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 135. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 136. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 138. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 140. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 141. SPAIN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 152. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 168. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 170. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 171. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 172. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 173. DENMARK CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 174. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 176. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 183. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 184. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 186. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 188. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 189. QATAR CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 191. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 192. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 194. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 195. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 196. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 197. FINLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 198. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 199. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 200. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 208. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 214. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 216. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 218. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 219. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 220. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 221. EGYPT CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 222. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 224. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 226. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 227. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 228. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 229. TURKEY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 231. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 232. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 238. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 239. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 240. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 242. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 243. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 244. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 245. NORWAY CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 246. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 247. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 248. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 250. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 251. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 252. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 253. POLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 254. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 255. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 256. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 262. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 263. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 264. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC CARDIAC POC TESTING DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 271. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 272. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 273. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 275. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 276. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 277. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 278. CHINA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 280. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 281. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 283. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 285. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 286. INDIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 287. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 288. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 289. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 291. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 292. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 293. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 294. JAPAN CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 295. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 297. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 303. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 304. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 305. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 311. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 312. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 313. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 319. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 320. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY TROPONIN, 2018-2030 (USD MILLION)
TABLE 321. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY HOSPITAL, 2018-2030 (USD MILLION)
TABLE 323. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 324. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 325. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 326. THAILAND CARDIAC POC TESTING DEVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. PHILIP

Companies Mentioned

The companies profiled in this Cardiac POC Testing Devices market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Siemens Healthineers AG
  • Danaher Corporation
  • Becton Dickinson and Company
  • bioMérieux SA
  • Quidel Corporation
  • Nova Biomedical, Inc.
  • Trinity Biotech plc
  • Chembio Diagnostics Systems, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages189
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.69 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.08 Billion
Compound Annual Growth Rate12.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Cardiac POC Testing Devices - Global Strategic Business Report - Product Image

Cardiac POC Testing Devices - Global Strategic Business Report

  • Report
  • 377 Pages
  • Global
From
Cardiac PoC Testing Devices Market 2025-2033 - Product Image

Cardiac PoC Testing Devices Market 2025-2033

  • Report
  • 136 Pages
  • Global
From
Cardiac Poc Testing Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032) - Product Image

Cardiac Poc Testing Devices Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

  • Report
  • 154 Pages
  • Global
From
Heart Failure POC & LOC Devices Market by Test Type (Genomic Testing, Metabolomic Testing, Proteomic Testing), Device Type (Diagnostic Devices, Wearable Devices), Technology, End User - Global Forecast 2025-2030 - Product Image

Heart Failure POC & LOC Devices Market by Test Type (Genomic Testing, Metabolomic Testing, Proteomic Testing), Device Type (Diagnostic Devices, Wearable Devices), Technology, End User - Global Forecast 2025-2030

  • Report
  • 180 Pages
  • Global
From
Cardiac Point of Care Testing Market by Product Type, End User, Distribution Channel, Test Mode, Technology, Application - Global Forecast to 2030 - Product Image

Cardiac Point of Care Testing Market by Product Type, End User, Distribution Channel, Test Mode, Technology, Application - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From

About the Cardiac POC Testing Devices Market

The Cardiac POC Testing Devices market is a subset of the Point-of-Care Diagnostics market, which focuses on providing rapid, accurate, and cost-effective diagnostic testing at the point of care. Cardiac POC Testing Devices are used to detect cardiac biomarkers, such as troponin, in order to diagnose and monitor cardiac conditions. These devices are typically portable, easy to use, and provide results in a short amount of time. This allows healthcare providers to quickly diagnose and treat cardiac conditions, reducing the risk of complications and improving patient outcomes. Some companies in the Cardiac POC Testing Devices market include Abbott, Roche, Siemens, and Alere. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.